News
12-13-2010, 09:10 AM
Many postmenopausal women with early-stage breast cancers who initially respond well to tamoxifen become resistant to the drug over time and develop recurrent tumors. Johns Hopkins Kimmel Cancer Center researchers have found that a gene called HOXB7 may be the culprit in tamoxifen resistance...
More... (http://mnt.to/f/3NYX)
More... (http://mnt.to/f/3NYX)